Jim Simons Enzo Biochem Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Enzo Biochem Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,527,529 shares of ENZ stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,527,529

Previous 2,499,546 1.12%

Holding current value

$1.87 Million

Previous $2.72 Million 3.89%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.04 - $1.18 $29,102 - $33,019	27,983 Added 1.12%	2,527,529 $2.83 Million
Q2 2024 Aug 09, 2024	BUY	$1.04 - $1.28 $66,993 - $82,453	64,417 Added 2.65%	2,499,546 $2.72 Million
Q1 2024 May 13, 2024	SELL	$1.21 - $1.5 $53,319 - $66,099	-44,066 Reduced 1.78%	2,435,129 $3.09 Million
Q4 2023 Feb 13, 2024	SELL	$1.21 - $1.44 $93,011 - $110,691	-76,869 Reduced 3.01%	2,479,195 $3.45 Million
Q3 2023 Nov 14, 2023	SELL	$1.3 - $1.87 $193,440 - $278,256	-148,800 Reduced 5.5%	2,556,064 $3.58 Million
Q2 2023 Aug 11, 2023	SELL	$1.84 - $2.66 $119,968 - $173,432	-65,200 Reduced 2.35%	2,704,864 $4.98 Million
Q1 2023 May 12, 2023	SELL	$1.0 - $2.51 $43,900 - $110,188	-43,900 Reduced 1.56%	2,770,064 $6.73 Million
Q4 2022 Feb 13, 2023	SELL	$1.16 - $2.42 $111,011 - $231,594	-95,700 Reduced 3.29%	2,813,964 $4.02 Million
Q3 2022 Nov 14, 2022	SELL	$2.1 - $2.73 $223,650 - $290,745	-106,500 Reduced 3.53%	2,909,664 $6.49 Million
Q2 2022 Aug 12, 2022	BUY	$2.0 - $3.0 $10,000 - $15,000	5,000 Added 0.17%	3,016,164 $6.24 Million
Q1 2022 May 13, 2022	SELL	$2.9 - $3.47 $242,440 - $290,092	-83,600 Reduced 2.7%	3,011,164 $8.73 Million
Q4 2021 Feb 11, 2022	SELL	$3.17 - $4.09 $365,501 - $471,577	-115,300 Reduced 3.59%	3,094,764 $9.93 Million
Q3 2021 Nov 12, 2021	SELL	$3.01 - $3.77 $148,092 - $185,484	-49,200 Reduced 1.51%	3,210,064 $11.4 Million
Q2 2021 Aug 13, 2021	SELL	$2.86 - $3.61 $233,376 - $294,576	-81,600 Reduced 2.44%	3,259,264 $10.3 Million
Q1 2021 May 13, 2021	SELL	$2.61 - $4.08 $562,086 - $878,664	-215,359 Reduced 6.06%	3,340,864 $11.5 Million
Q4 2020 Feb 10, 2021	SELL	$1.82 - $2.61 $55,510 - $79,605	-30,500 Reduced 0.85%	3,556,223 $8.96 Million
Q3 2020 Nov 13, 2020	BUY	$2.02 - $3.02 $245,318 - $366,763	121,445 Added 3.5%	3,586,723 $7.57 Million
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.22 $324,996 - $493,626	153,300 Added 4.63%	3,465,278 $7.76 Million
Q1 2020 May 14, 2020	SELL	$1.82 - $3.87 $76,130 - $161,882	-41,830 Reduced 1.25%	3,311,978 $8.38 Million
Q4 2019 Feb 13, 2020	BUY	$2.57 - $3.68 $139,409 - $199,621	54,245 Added 1.64%	3,353,808 $8.82 Million
Q3 2019 Nov 13, 2019	BUY	$3.01 - $4.0 $146,075 - $194,120	48,530 Added 1.49%	3,299,563 $11.9 Million
Q2 2019 Aug 12, 2019	BUY	$2.79 - $4.31 $183,593 - $283,615	65,804 Added 2.07%	3,251,033 $11 Million
Q1 2019 May 14, 2019	BUY	$2.54 - $4.02 $247,799 - $392,187	97,559 Added 3.16%	3,185,229 $8.7 Million
Q4 2018 Feb 13, 2019	BUY	$2.46 - $4.2 $7.6 Million - $13 Million	3,087,670 New	3,087,670 $8.58 Million

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.5M

Call Options Held

2.3K

Put Options Held

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $36.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account